Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 2
1958 1
1961 1
1962 1
1963 1
1964 2
1965 2
1966 3
1968 1
1969 7
1970 3
1971 2
1972 6
1973 5
1974 4
1975 6
1976 7
1977 10
1978 14
1979 23
1980 19
1981 21
1982 22
1983 24
1984 15
1985 32
1986 34
1987 26
1988 24
1989 25
1990 30
1991 15
1992 31
1993 29
1994 28
1995 19
1996 25
1997 24
1998 17
1999 34
2000 20
2001 20
2002 30
2003 35
2004 28
2005 51
2006 42
2007 32
2008 40
2009 35
2010 46
2011 45
2012 50
2013 33
2014 50
2015 51
2016 46
2017 49
2018 49
2019 60
2020 65
2021 48
2022 68
2023 73
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,569 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Management of Pituitary Adenomas: A Review.
Tritos NA, Miller KK. Tritos NA, et al. JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444. JAMA. 2023. PMID: 37097352 Review.
IMPORTANCE: Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell lineage and include functioning tumors, characterized by the secretion of pituitary hormones, and nonfunctioning tumors. ...Patients with macroadenomas additionally require evaluation for h …
IMPORTANCE: Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell lineage and include functioning tumors, character …
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA; Endocrine Society. Melmed S, et al. J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692. J Clin Endocrinol Metab. 2011. PMID: 21296991 Review.
These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas ar …
These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing …
Diagnosis and Treatment of Pituitary Adenomas: A Review.
Molitch ME. Molitch ME. JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699. JAMA. 2017. PMID: 28170483 Review.
Growth hormone-secreting tumors account for 8% to 16% of tumors and usually present with enlargement of the lips, tongue, nose, hands, and feet and are diagnosed by elevated insulin-like growth factor 1 levels and growth hormone levels; initial treatment is surgical. Medical t …
Growth hormone-secreting tumors account for 8% to 16% of tumors and usually present with enlargement of the lips, tongue, nose, hands, and f …
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.
Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Nieman LK, et al. J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29. J Clin Endocrinol Metab. 2015. PMID: 26222757 Free PMC article.
The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient....
The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), …
The Diagnosis and Treatment of Craniopharyngioma.
Müller HL. Müller HL. Neuroendocrinology. 2020;110(9-10):753-766. doi: 10.1159/000504512. Epub 2019 Nov 4. Neuroendocrinology. 2020. PMID: 31678973 Free article. Review.
If the tumor is favorably localized, the therapy of choice is complete resection, with care taken to preserve the optical and hypothalamic functions. In patients with unfavorable tumor localization (i.e., hypothalamic involvement), the recommended t …
If the tumor is favorably localized, the therapy of choice is complete resection, with care taken to preserve the optical and …
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.
Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S. Petersenn S, et al. Nat Rev Endocrinol. 2023 Dec;19(12):722-740. doi: 10.1038/s41574-023-00886-5. Epub 2023 Sep 5. Nat Rev Endocrinol. 2023. PMID: 37670148 Review.
In-depth discussions present the latest evidence on treatment of prolactinoma, including efficacy, adverse effects and options for withdrawal of dopamine agonist therapy, as well as indications for surgery, preoperative medical therapy and radiation therapy. …
In-depth discussions present the latest evidence on treatment of prolactinoma, including efficacy, adverse effects and options for withdrawa …
The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
Chanson P, Maiter D. Chanson P, et al. Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101290. doi: 10.1016/j.beem.2019.101290. Epub 2019 Jul 10. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31326373 Review.
Macroprolactin, responsible for pseudohyperprolactinemia is a frequent pitfall of prolactin assay. DAs still represent the primary therapy for most prolactinomas, but neurosurgery has regained interest, due to progress in surgical techniques and a high success rate in micr …
Macroprolactin, responsible for pseudohyperprolactinemia is a frequent pitfall of prolactin assay. DAs still represent the primary therap …
Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P. Dimitri P. Front Endocrinol (Lausanne). 2022 Apr 6;13:846880. doi: 10.3389/fendo.2022.846880. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35464063 Free PMC article. Review.
A well-defined approach to defining the location of hypothalamic damage may support the use of future targeted therapies. ...This article discusses the current challenges in the management of hypothalamic obesity in children and young people and future the …
A well-defined approach to defining the location of hypothalamic damage may support the use of future targeted therapies. ...T …
Management of clinically non-functioning pituitary adenoma.
Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S; French Endocrinology Society non-functioning pituitary adenoma work-group. Chanson P, et al. Ann Endocrinol (Paris). 2015 Jul;76(3):239-47. doi: 10.1016/j.ando.2015.04.002. Epub 2015 Jun 10. Ann Endocrinol (Paris). 2015. PMID: 26072284 Free article. Review.
Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC, Valk GD. Pieterman CRC, et al. Clin Endocrinol (Oxf). 2022 Oct;97(4):409-423. doi: 10.1111/cen.14727. Epub 2022 Apr 1. Clin Endocrinol (Oxf). 2022. PMID: 35319130 Free PMC article. Review.
Pituitary adenomas are most often prolactinomas and nonfunctioning microadenomas with an excellent prognosis and good response to therapy. Breast cancer is recognized as part of the MEN1 syndrome in women and periodical screening is advised. ...In conclusion, patient outco …
Pituitary adenomas are most often prolactinomas and nonfunctioning microadenomas with an excellent prognosis and good response to therapy …
1,569 results